Abstract
Peritoneal metastasis is the most important prognostic factor for gastric and ovarian cancer patients. The protocol in this chapter presents in vivo imaging procedures capable of examining the development of peritoneal metastasis from the micrometastasis stage to the advanced stage. We also describe in vivo imaging procedures for monitoring of antimetastatic agents in nude mice. In vivo imaging systems described consist of green fluorescent protein (GFP) or red fluorescent protein (DsRed) gene-tagged metastatic cancer cell lines and a handy detection device for GFP (or DsRed). This system allows both external, noninvasive, and real-time monitoring of the therapeutic effects of drugs within the animal facility and internal visualization of micrometastases at the cellular level using fluorescence microscopy. Selection of micrometastasis-positive mice and timing of drug administration after injection of tumor cells is critical for accurate evaluation of anti-metastatic efficacy. The present real-time fluorescence imaging system using GFP- and DsRed-tagged metastasis models makes it possible to overcome these problems and therefore is an indispensable tool for preclinical metastasis research and drug discovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Moriguchi, S., Maehara, Y., Korenaga, D., Sugimachi, K., and Nose, Y. (1992) Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg. Oncol., 1, 341–346.
Yonemura, Y., Fujimura, T., Nishimura, G., Falla, R., Sawa, T., Katayama, K., Tsugawa, K., Fushida, S., Miyazaki, I., Tanaka, M., Endou, Y., and Sasaki, T. (1996) Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery, 119, 437–44.
Sautner, T., Hofbauer, F., Depisch, D., Schiessel, R., and Jakesz, R. (1994) Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J. Clin. Oncol., 12, 970–974.
Yokoyama, H., Ikehara, Y., Kodera, Y., Ikehara, S., Yatabe, Y., Mochizuki, Y., Koike, M., Fujiwara, M., Nakao, A., Tatematsu, M., Nakanishi, H. (2006) Molecular basis for sensitivity and acquired resistance to gefitinib in HER2 overexpressing human gastric cancer cell lines derived from liver metastasis. Br J Cancer. 95, 1504–1513.
Hara, M., Nakanishi, H., Tsujimura, K., Matsui, M., Yatabe, Y., Manabe, T., and Tatematsu, M. (2008) Interleukin-2 potentiation of cetuximab anti-tumor activity for EGFR overexpressing gastric cancer xenografts via antibody-dependent cellular cytotoxicity. Cancer Sci. 99(7), 1471–8.
Yanagihara,K,. Takigahira, M,. Tanaka,H,. Komatsu, T,. Fukumoto, H,. Koizumi,F,. Nishio, K,. Ochiya, T,. Ino, Y,. Hirohashi,S. (2005) Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci. 96(6), 323–32.
Nakanishi, H., Ito, S., Mochizuki, Y., Tatematsu, M. (2005) Evaluation of chemosensitivity of micrometastases with green fluorescent protein-tagged tumor models in mice. In Chemosensitivity for Methods in Molecular Medicine [Blumenthal, R. D.,ed.].Humana Press, Totowa, NJ. Vol 111, 351–362.
Misteli, T., and Spector, D.L. (1997) Applications of the green fluorescent protein in cell biology and biotechnology. Nat. Biotechnol. 15, 961–964.
Chishima, T., Miyagi, Y., Wang, X., Yamaoka, H., Shimada, H., Moossa, A. R., Hoffman, R. M. (1997) Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res. 57(10), 2042–2047.
Yang, M., Baranov, E., Jiang, P., Sun, F. X., Li, X. M., Li, L., Hasegawa, S., Bouvet, M., Al-Tuwaijri, M., Chishima, T., Shimada, H., Moossa, A. R., Penman, S., Hoffman, R. M. (2000) Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci USA. 97 (3), 1206–1211.
Hoffman, R. M. (1999) Orthotopic transplant mouse models with green fluorescent protein-expressing cancer cells to visualize metastasis and angiogenesis. Cancer Metastasis Rev. 17, 271–277.
Hoffman, R. M. (2002) Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Lancet Oncol. 3(9), 546–56.
Hoffman, R.M. (2005) In vivo cell biology of cancer cells visualized with fluorescent proteins. Curr Top Dev Biol. 70, 121–44
Zhou, J., Yu, Z., Zhao, S., Hu, L., Zheng, J., Yang, D., Bouvet, M., Hoffman, R.M. (2009) Lentivirus-based DsRed-2-transfected pancreatic cancer cells for deep in vivo imaging of metastatic disease. J Surg Res. 157(1), 63–70.
Yang, M., Jiang, P., Hoffman, R.M. (2007) Whole-body subcellular multicolor imaging of tumor-host interaction and drug response in real time. Cancer Res. 67(11), 5195–200.
Yokoyama, H., Nakanishi, H., Kodera,Y., Ikehara, Y., Ohashi, N., Ito, Y., Koike, M., Fujiwara, M., Tatematsu, M., Nakao, A. (2006) Biological significance of isolated tumor cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein (GFP)-tagged human gastric cancer cell line. Clin. Cancer Res. 12(2); 361–68.
Buchhorn, H.M., Seidl, C., Beck, R., Saur, D., Apostolidis, C., Morgenstern, A., Schwaiger, M., Senekowitsch-Schmidtke, R. (2007) Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after 213Bi-radioimmunotherapy using bioluminescence imaging. Eur J Nucl Med Mol Imaging. 34(6), 841–9.
Nakanishi, H., Mochizuki, Y., Kodera, Y., Ito S., Yamamura, Y., Ito, K., Akiyama, S., Nakao, A., Tatematsu, M. (2003) Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Cancer Sci. 94(1), 112–118.
Ito, Y., Nakanishi, H., Kodera, Y., Hirai, T., Nakao, A., Kato, T. (2010) Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/LV. Cancer Sci. 101(8), 1853–1860.
Nakanishi, H., Ito, S., Mochizuki,Y., Ohashi, N., Ikehara, Y., Yamamura, Y., Kodera,Y. (2007) Peritoneal carcinomatosis; A new diagnostic and therapeutic strategy. In Research Focus on Gastric Cancer. Edited by Cardinni DC., Nova Scientific Publishers. pp. 55–73.
Ohashi, N., Kodera, Y., Nakanishi, H., Yokoyama, H., Fujiwara, M., Koike, M., Hibi, K., Nakao, A., Tatematsu, M. (2005) Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice. Int. J. Oncol. 27(3), 637–44.
Nakanishi, H., Hara, H., Ikehara, Y., Tatematsu, M., (2007) Non-invasive and real-time monitoring of molecular targeting therapy for lymph node and peritoneal metastasis in nude mice bearing xenografts of human colorectal cancer cells tagged with GFP and DsRed, Proceeding of SPIE, 6449; 644910–1-9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this protocol
Cite this protocol
Nakanishi, H., Ito, S., Matsui, M., Ito, Y., Misawa, K., Kodera, Y. (2012). Noninvasive and Real-Time Fluorescence Imaging of Peritoneal Metastasis in Nude Mice. In: Hoffman, R. (eds) In Vivo Cellular Imaging Using Fluorescent Proteins. Methods in Molecular Biology, vol 872. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-797-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-61779-797-2_6
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-796-5
Online ISBN: 978-1-61779-797-2
eBook Packages: Springer Protocols